MED-EL SONNET 2 Processor

SONNET 2 Next Generation Audio Processor with MAESTRO 8 Software Now Available from MED-EL USA

MED-EL SONNET 2

Processor Pairs to New Remote Options AudioKey App and FineTuner Echo for Optimal Control and Connectivity

January 6, 2020 – (DURHAM, NC) – MED-EL USA announced today that the new SONNET 2 audio processor is now available. Because MED-EL cochlear implants are engineered for future-readiness, recipients with any MED-EL internal system can enjoy the benefits of the new SONNET 2. The processors are programmed using the recently FDA-approved MAESTRO 8 software that has been optimized for audiologists with guided workflows that show each step in the fitting process, suggesting tasks and tools along the way. The updated software also includes extended data logging functions for hearing health professionals.

SONNET 2 connects to smartphones and tablets using Bluetooth and the new AudioLink device, which is also now available, so that users can stream phone calls and music wirelessly to their ears. Users can choose how they would like to change settings: either from the AudioKey app (available for both iPhones and Android devices) or the FineTuner Echo remote control, both of which were also launched today.

Both the AudioKey app and the FineTuner Echo enable recipients to adjust the volume and switch between programs on their SONNET 2. AudioKey offers a number of family-friendly tools including a special “find my processor” feature that allows users to locate a missing SONNET 2 processor with a near-field search within one meter. With the industry-leading “Guardian Role” function, adults can adjust the settings on a child’s audio processor from a phone and keep a record of their hearing statistics. AudioKey is the only app that allows parents to pair more than one audio processor with their phone, which is ideal if they have multiple children with cochlear implants. AudioKey is also the only app where parents and guardians can assign different levels of control to multiple people, so that every caregiver (including teachers, daycare sitters, grandparents, and even the user as they mature) can observe, control or administrate the recipient’s processors from their own phones.

For recipients who prefer an independent remote control, the new pocket-size FineTuner Echo offers an intuitive display screen that makes it simple to adjust settings, and an e-ink display that makes the screen easy to read on sunny days. The FineTuner Echo allows users to test the microphones of their or their child’s audio processor to quickly check if a device is working correctly.

“The seamless compatibility between SONNET 2, FineTuner Echo and AudioKey offers our cochlear implant users the latest in audio processing technology and wireless connectivity,” said Raymond Gamble, President & CEO, MED-EL North America. “We are particularly excited about family-friendly features like ‘Find my Processor’ and ‘Guardian Role’ that can help alleviate some of the more stressful scenarios for parents of children with cochlear implants. We also know that the unique ability to pair AudioKey to more than one audio processor is a real benefit to families with more than one MED-EL recipient.”

For more information about SONNET 2, FineTuner Echo, AudioKey or any of MED-EL’s products, visit https://www.JourneytoBetterHearing.com/.

About MED-EL

MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world’s first microelectronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and was the basis for what is known as the modern CI today. This laid the foundation for the successful growth of the company in 1990, when they hired their first employees. To date, MED-EL has grown to more than 2,000 employees and 30 locations worldwide.

The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 123 countries to enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear and middle ear implant systems, a combined Electric Acoustic Stimulation hearing implant system as well as surgical and non-surgical bone conduction systems. www.medel.com

iOS 13 Streaming with Cochlear Nucleus 7 Processors Update

Information for users of direct MFi streaming sound processors:

Since updating to iOS 13, some users of hearing devices with MFi (Made for iPhone) connectivity may be experiencing issues with the connection between their hearing device and their Apple device as well as with streaming quality.

NUCLEUS® 7 OR BAHA® 5 SOUND PROCESSOR USERS

Nucleus® 7 or Baha® 5 Sound Processor users, who have recently updated to iOS 13 (released 20 September 2019) and subsequent updates through to iOS 13.1.2 (released 1 October 2019) may experience the following issues:

  • Issue: The Apple device is not streaming audio to the sound processor.
    We recommend you turn the sound processor off and back on again. If this does not resolve the issue, try unpairing and re-pairing the sound processor to the Apple device.
  • Issue: Various MFi pairing and unpairing issues.
    We recommend unpairing and re-pairing the sound processor. If this does not resolve the issue, try restarting the Apple device and then pair your sound processor.
  • Issue: When using an iPhone, the Keyboard ‘click’ and other device sounds are being streamed to the sound processor. In addition, there is a reduction in the sound processor’s microphone volume.
    We recommend you set the ringer/mute switch on the iPhone to silent while streaming. This stops the device sounds from streaming. Don’t forget to turn the ringer/mute back to audible after you finish streaming.
    or
    Go to Settings> Sounds & Haptics> Keyboard Clicks. Turning this off will stop the keyboard sounds. Repeat this process to turn the keyboard sounds back on again.

Cochlear is working with Apple to resolve these issues. Apple have requested that Cochlear customers report their issues directly to them by sending an email:  accessibility@apple.com

AudioLink and SONNET Benefits for new MED-EL Recipients

MED-EL USA announces two programs for new recipients in the USA or Canada.

  • You will receive a voucher for the AudioLink handsfree wireless technology interface (Bluetooth gateway device) that is expected to be available in Fall 2019.
  • A new SONNET Swap program where new US recipients with an unopened  SONNET EAS audio processor can exchange it for the next generation SONNET (already known as SONNET 2 in other markets) once it becomes available, also expected late 2019.

Read the full press release here.

Cochlear Announces MRI-Safe Implant

Cochlear announces the launch of the Nucleus® Profile Plus Series implant, designed for routine 1.5 and 3 Tesla magnetic resonance imaging scans without the need to remove the internal magnet.

Initial availability is in Germany, appearing in other markets pending regulatory approval.

With this announcement, all three major cochlear implant manufacturers offer up to 3T MRI compatibility without removal of the internal magnet.  More information on the differences between options will be forthcoming.

Advanced Bionics Chorus Processor for C1 Available Now

Advanced Bionics announces US availability of the Chorus processor for C1.0 and C1.2 recipients.  Chorus offers several great features for recipients of these legacy implants, including:

  • All-day hearing on one rechargeable battery
  • Significantly smaller than the Platinum Sound Processor
  • Roger technology integrated in the processor
  • Comes with your choice or Roger Pen or Roger Select
  • Waterproof wearing options

Learn more at Advanced Bionics!

Cochlear Announces Next Phase in Development of Totally Implantable Cochlear Implant Technology

Cochlear Limited today announced the next phase in its long-term research and development program towards a totally implantable cochlear implant, with the start of a further clinical feasibility study. The development of totally implantable cochlear implant technology is complex, and a commercially available product is not expected for years; however, it remains a long-term development goal for Cochlear.

Editor’s note:  Clinical trials provide no guarantee that a product will be available in a given time frame, or even at all.  If you are considering a cochlear implant and have questions about potential future developments, please discuss them with your hearing professional.

 

MED-EL RONDO 2 Receives FDA Approval

MED-EL RONDO 2

MED-EL announced today the US Food and Drug Administration (FDA) approval of the RONDO 2 cochlear implant audio processor.  Just place the RONDO 2 on the charge pad and it will charge automatically without wires or cables. The rechargeable battery provides up to 18 hours of battery life, and recharges after four hours.

Product availability is estimated in Fall 2018.  For more information, read the press release here.